LLY

733.18

-2.5%↓

JNJ

153.97

-1.02%↓

UNH

380.38

-1.39%↓

ABBV

184.25

-0.64%↓

ABT

133.26

-0.42%↓

LLY

733.18

-2.5%↓

JNJ

153.97

-1.02%↓

UNH

380.38

-1.39%↓

ABBV

184.25

-0.64%↓

ABT

133.26

-0.42%↓

LLY

733.18

-2.5%↓

JNJ

153.97

-1.02%↓

UNH

380.38

-1.39%↓

ABBV

184.25

-0.64%↓

ABT

133.26

-0.42%↓

LLY

733.18

-2.5%↓

JNJ

153.97

-1.02%↓

UNH

380.38

-1.39%↓

ABBV

184.25

-0.64%↓

ABT

133.26

-0.42%↓

LLY

733.18

-2.5%↓

JNJ

153.97

-1.02%↓

UNH

380.38

-1.39%↓

ABBV

184.25

-0.64%↓

ABT

133.26

-0.42%↓

Search

Pulmatrix Inc

Slēgts

6.04 1.34

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

6.04

Max

6.11

Galvenie mērījumi

By Trading Economics

Ienākumi

601K

-2M

Pārdošana

-363K

3K

EPS

-0.544

Peļņas marža

-66,200

Darbinieki

2

EBITDA

705K

-2M

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

-2.7M

23M

Iepriekšējā atvēršanas cena

4.7

Iepriekšējā slēgšanas cena

6.04

Pulmatrix Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 11. maijs 23:48 UTC

Peļņas
Iegādes, apvienošanās, pārņemšana

Dyno Nobel Returns to 1st Half Profit; Strikes Fertilizers Deals -- Update

2025. g. 11. maijs 23:46 UTC

Tirgus saruna

Nikkei May Rise on Hopes for U.S.-China Trade Talks -- Market Talk

2025. g. 11. maijs 23:45 UTC

Tirgus saruna

Oil Rises Amid Improved Market Mood -- Market Talk

2025. g. 11. maijs 23:38 UTC

Tirgus saruna
Iegādes, apvienošanās, pārņemšana

Aristocrat Has Significant Firepower for M&A -- Market Talk

2025. g. 11. maijs 23:36 UTC

Tirgus saruna

Global Markets Uncertain About US-China Trade News -- Market Talk

2025. g. 11. maijs 23:35 UTC

Tirgus saruna

Gold Falls, Dragged by Weakening Safe-Haven Demand, Possible Profit-Taking -- Market Talk

2025. g. 11. maijs 23:33 UTC

Peļņas
Iegādes, apvienošanās, pārņemšana

Dyno Nobel Returns to 1H Profit; Strikes Fertilizers Deals -- Update

2025. g. 11. maijs 23:32 UTC

Top Ziņas

Proposal Cutting Medicaid Aims for GOP Middle Ground -- WSJ

2025. g. 11. maijs 22:44 UTC

Tirgus saruna

Centaurus Metals's Jaguar Project Faces Funding Hurdles -- Market Talk

2025. g. 11. maijs 22:33 UTC

Tirgus saruna
Iegādes, apvienošanās, pārņemšana

Domain Takeover Could Create Near-Term Overhang on REA Stock -- Market Talk

2025. g. 11. maijs 20:19 UTC

Top Ziņas

Bessent Says U.S.-China Trade Talks Were 'Productive,' Without Offering Specifics -- WSJ

2025. g. 11. maijs 16:00 UTC

Top Ziņas

Trump's Budget Hawk Takes Over the DOGE Agenda. First Up: the Military -- WSJ

2025. g. 11. maijs 11:00 UTC

Top Ziņas

This Obscure New York Court Is Set to Decide Fate of Trump's Tariffs -- WSJ

2025. g. 11. maijs 08:00 UTC

Top Ziņas

China's Property Market Is a Tale of Big Cities. Everywhere Else Is Struggling. -- Barrons.com

2025. g. 11. maijs 01:00 UTC

Top Ziņas

The Spring Home Sales Season Is Shaping Up to Be a Dud -- WSJ

2025. g. 11. maijs 01:00 UTC

Top Ziņas

Europe Threatens Nord Stream 2 Sanctions to Pressure Russia on Cease-Fire -- WSJ

2025. g. 10. maijs 21:54 UTC

Top Ziņas

GOP Tax Bill Seeks to Put Cash in Taxpayers' Pockets in Early 2026 -- Update

2025. g. 10. maijs 17:12 UTC

Top Ziņas

Europe Threatens Nord Stream 2 Sanctions to Pressure Russia to Cease Fire -- WSJ

2025. g. 10. maijs 15:41 UTC

Top Ziņas

Fed Officials Signal Pause on Adjusting Interest Rates as Trade Risks Mount -- Barrons.com

2025. g. 10. maijs 12:00 UTC

Top Ziņas

Why a Sorority Is Taking on Trump's Budget Cuts -- WSJ

2025. g. 10. maijs 09:30 UTC

Top Ziņas

The Giants of Silicon Valley Are Having a Midlife Crisis Over AI -- WSJ

2025. g. 10. maijs 08:20 UTC

Tirgus saruna

Tech, Media & Telecom Roundup: Market Talk

2025. g. 10. maijs 03:52 UTC

Top Ziņas

China Struggles With Persistent Disinflationary Pressures as Tariffs Bite -- WSJ

2025. g. 9. maijs 23:51 UTC

Iegādes, apvienošanās, pārņemšana

Oil at $50? The High Cost of Cheap Crude. -- Barrons.com

2025. g. 9. maijs 22:06 UTC

Tirgus saruna

Arm Holdings Remains a Strong Growth Story -- Market Talk

2025. g. 9. maijs 21:37 UTC

Top Ziņas

U.S. Sets August Deadline for Debt Ceiling -- WSJ

2025. g. 9. maijs 21:10 UTC

Top Ziņas

The Score: Disney, Berkshire Hathaway, Ford and More Stocks That Defined the Week -- WSJ

2025. g. 9. maijs 20:50 UTC

Tirgus saruna

Tech, Media & Telecom Roundup: Market Talk

2025. g. 9. maijs 20:50 UTC

Tirgus saruna

Health Care Roundup: Market Talk

2025. g. 9. maijs 20:42 UTC

Top Ziņas

Stocks Get a Break From Trade Chaos -- WSJ

Salīdzinājums

Cenas izmaiņa

Pulmatrix Inc Prognoze

Vērtējuma vienprātība

By TipRanks

0 ratings

0

Pirkt

0

Turēt

0

Pārdot

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Pulmatrix Inc

Pulmatrix, Inc., a clinical stage biotechnology company, focused on development of novel inhaled therapeutic products to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery platform, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. It engages in developing PUR1800, a narrow spectrum kinase inhibitor completed Phase 1b clinical trials for the treatment of acute exacerbations in chronic obstructive pulmonary disease; PUR1900 for the treatment of allergic bronchopulmonary aspergillosis in patients with asthma and cystic fibrosis; and PUR3100, an iSPERSE formulation of dihydroergotamine which is in Phase 1 for the treatment of acute migraine. It has a license agreement with RespiVert Ltd. for access to a portfolio of kinase inhibitor drug candidates. The company was founded in 2003 and is headquartered in Bedford, Massachusetts.